Back to Trials
NCT03478553RecruitingAccepts Healthy Volunteers

The Genetics of Pulmonary Fibrosis

University of Colorado, Denver

Start Date

1/18/2018

Completion Date

12/31/2026

Summary

This study seeks to screen first degree family members of people with Idiopathic Pulmonary Fibrosis (IPF) for the earliest signs of lung fibrosis.

Detailed Description

The purpose of this study is to explore genetic factors associated with the development of pulmonary fibrosis. The investigators aim is to identify and explore genetic loci that affect development of pulmonary fibrosis and also explore related environmental exposures. Idiopathic pulmonary fibrosis (IPF) is one of the interstitial lung diseases under the broader umbrella of idiopathic interstitial pneumonias (IIP). The investigators hypothesize that inherited genetic factors are associated with pulmonary fibrosis. To investigate the genetics of pulmonary fibrosis, the investigators plan to enroll individuals with pulmonary fibrosis and their family members.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Age at least 18 years old * Family member diagnosed with IPF Exclusion Criteria: \- No family member with IPF

Interventions

OTHER

Blood draw

OTHER

Questionnaire

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Locations

University of Colorado Anschutz Medical Campus

Aurora, Colorado 80045

United States